ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

Symposium Addresses FCC issues

February 21, 1986

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

Includes January Business & Regulatory Report (8-page issue).

January 31, 2003

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010